Please note that this event is already in progress or has finished.
It might be possible to obtain information from the organiser about similar future events
[or if available notes/abstract from this meeting].

Please check out any links below - if these are not of any help then contact the organiser using the "Inquire" button below.

Go to current meetings

Date: 15th March - 1st September, 2012

Location: On-Line, USA

Summary:
Clinical - Training

Description:
The use of molecular tests is expected to increase in medical settings where technical knowledge may be limited. To bridge this gap, CLSI document MM19, Establishing Molecular Testing in Clinical Laboratory Environments; Approved Guideline, provides guidance for strategic planning, facility design, implementation, and quality management for introduction of molecular diagnostic clinical programs.

Objectives:
At the conclusion of this program, the participant will be able to:
Apply SWOT (strengths, weaknesses, opportunities, and threats) analysis techniques to laboratory strategic planning for implementation of specific programs and assays.

Describe the elements of a comprehensive molecular testing laboratory implementation plan. Identify the unique testing considerations for the different clinical areas that are addressed by molecular diagnostics, including heritable disease testing, oncology/malignant hematology, pharmacogenomics, and infectious disease.

Faculty:
Leslie Hall, MMSc, RM(NRM), M(ASCP) Development Technologist Coordiantor, Division of Clinical Microbiology at the Mayo Clinic

Cosponsored by CLSI

Click for more information